Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis. Petrelli F, Rea C, Parati MC, Borgonovo K, et al. Anticancer Res 2023;43:4303-4313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Petrelli F, Rea C, Parati MC, Borgonovo K, et al. Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis. Anticancer Res 2023;43:4303-4313.
PMID: 37772569